The patient has osteoporosis, which may also be caused by these 4 drugs

*For medical professional reading reference only

Don't forget to ask the patient's medication history!

Osteoporosis (OP) is a systemic bone metabolic disorder characterized by low bone mineral content, damage to bone microstructure, and reduced bone strength, resulting in increased bone fragility and susceptibility to fractures

The anticoagulant - warfarin

Warfarin can inhibit the carboxylation of osteocalcin and reduce bone calcium deposition, thereby interfering with bone metabolism, leading to osteoporosis or fractures, and the risk of long-term use is greater

3.

Thiazolidinediones (TZDs) are a new class of drugs that increase insulin sensitivity.

The proton pump inhibitor - omeprazole

Proton pump inhibitors (PPIs) are commonly used drugs for peptic ulcer.

Summarize

Drug-induced osteoporosis (DIO) seriously affects the quality of life of patients, easily causing falls, fractures and even life-threatening.

[1] Chinese Medical Association Osteoporosis and Bone Mineral Disease Branch.
Guidelines for the diagnosis and treatment of primary osteoporosis (2011) [J].
Chinese Journal of Osteoporosis and Bone Mineral Disease, 2011, 4 (1) : 2-17．[2] Liu Zhonghou.
Osteoporosis [M].
Beijing: Science Press, 1998: 372-373.
[3] Wang Xiaolei, Wang Weihong, Dong Xinhong.
A systematic review of the effect of proton pump inhibitors on fracture risk [J].
Chinese Journal of Evidence-Based Medicine, 2012, 12(2): 216-223.
[4] Mazziotti G, CanalisE, Giustina A,et al.
Drug-induced osteoporosis: mechanisms and clinicalimplications[J].
Am J Med,2010,123(10):877-884.
[5]Wang Rong,Li Li.
Zoledronate in the treatment of osteoporosis Clinical Observation of Symptoms[J].
Electronic Journal of Modern Medicine and Health Research,2018,2(7):84-84.
[6]Home PD,Pocock SJ,Beck-Nielsen H,et al.
Rosiglitazone evaluated for cardiovascular outcomes inoral agent Combination therapy for type 2 diabetes ( RECORD ): A multicentre, randomised, open-label trial.
Lancet, 2009, DOI: 10.
1016/S0140-6736(09)60953-3.
[7] Hou Jianming, Li Jianwei, Lin Qingming, et al.
Changes of bone mineral density in patients with type 2 diabetes mellitus complicated with peripheral vascular disease.
Chinese Physician Journal.
2006, 29(11): 46-48.
[8] Zhao Liwei, Liu Gaifang, Wu Jing, etc.
Long-term application of proton pump inhibitors in elderly patients affects bone density Research on the influence of porosity［J］.
Chongqing Medical Science, 2017, 46(13): 1768-1769.
[9] Cai Ying, Cong Xu, Fei Ran.
Effects of Helicobacter pylori, omeprazole and gastrin on proliferation and apoptosis of gastric mucosal epithelial cells.
Chinese Medical Journal, 2010, 90(5): 2558-2563

This article was first publishedResponsible Editor of Drug Evaluation CenterCao Qian

Copyright statement
This article is reprinted.
Welcome to forward
it to Moments-End-Submission/reprint/business cooperation, please contact: pengsanmei@yxj.
org.
cn